ArticleTargeted oncology2021

The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib.

Anna Buder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.